Bioethics Council: Gene-Editing Human Embryos Conditionally OK
Shawna Williams | Jul 17, 2018
The UK-based organization encourages public debate about the issue but does not recommend immediate policy change.
Gene-Edited Skin Patch Prevents Cocaine Overdose in Mice
Gene-Edited Skin Patch Prevents Cocaine Overdose in Mice
With a built-in supply of a powerful cocaine-chomping enzyme, the transplant might also curb addiction.
With a built-in supply of a powerful cocaine-chomping enzyme, the transplant might also curb addiction.
Electric Shock Allows for CRISPR Gene Editing Without a Viral Vector
Ashley Yeager | Jul 12, 2018
Brief electroporation appears to make T cells more receptive to new genetic material, which could speed the development of immunotherapies.
CRISPR Trial for Cancer Patients Proposed
Katarina Zimmer | Jan 19, 2018
US researchers could become the first outside China to use the gene-editing technique in the clinic.
CRISPR to Debut in Clinical Trials
Diana Kwon | Dec 14, 2017
The first industry-sponsored CRISPR therapy is slated to be tested in humans in 2018.
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.
Scientists Edit Viable Human Embryos in U.S.
Kerry Grens | Jul 27, 2017
The embryos, whose genes were altered by CRISPR, were not intended for implantation.
Gene Editing: From Roots to Riches
Amanda B. Keener | Oct 1, 2016
Advances in genetic manipulation have simplified the once daunting task of rewriting a gene.
CRISPR Therapy to Enter Trials
Jef Akst | Jul 25, 2016
Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.
Considering Gene Editing
Jef Akst | Jul 12, 2016
An international committee continues its investigation into the ethical and social considerations of precision DNA editing technology with a public meeting held this morning in Washington, DC.